Healthcare Industry News: neurostimulation
News Release - January 3, 2007
Northstar Neuroscience Awarded U.S. Patent for Cortical Stimulation TherapyPatent Applies to a Number of Applications for Cortical Stimulation
SEATTLE--(HSMN NewsFeed)--Northstar Neuroscience, Inc. (Nasdaq: NSTR ), a developer of innovative medical devices for the treatment of neurological diseases and disorders, today announced that it has been awarded patent number 7,146,217 by the U.S. Patent and Trademark Office (USPTO) for its cortical stimulation therapy system. This patent includes important claims covering the use of cortical stimulation therapy for Northstar's lead clinical program for stroke recovery, as well as other applications involving brain injury and other disorders. The patent, which in part includes material initially filed in the USPTO in July 2000, is one of many early neurostimulation patents and patent applications owned by Northstar.
Cortical stimulation refers to the process of stimulating the cerebral cortex, or the outermost layer of the brain. Among other aspects of cortical stimulation, this patent includes important claims related to inducement and/or enhancement of neuroplasticity--the brain's ability to form new neural connections and improve function. The patent applies to the use of cortical stimulation in various ways, including:
- treating brain damage (such as stroke or trauma) and various disorders resulting from damage to the brain
- enhancing cognitive function including memory or learning and sensory functions
Northstar has a number of other IP filings currently pending in U.S., European and other patent offices.
About Northstar Neuroscience
Northstar Neuroscience, Inc. is a medical device company focused on developing and commercializing innovative neurostimulation therapies to restore function and quality of life for people suffering from stroke and other neurological diseases and disorders. Northstar's cortical stimulation therapy system is an investigational device that is in clinical trials for several indications, including stroke motor recovery, aphasia, tinnitus and depression. For more information, visit www.northstarneuro.com.
Source: Northstar Neuroscience
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.